EP3925956
1H-INDAZOLE-3-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS FACTOR D INHIBITORS FOR TREATING DISEASES CHARACTERIZED BY ABERRANT COMPLEMENT SYSTEM ACTIVITY, SUCH AS E.G. IMMUNOLOGICAL DISORDERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
1.2.2017EP published:
10.4.2024EP application number:
21173901.6
EPO information:
European Patent Register
Max expiry date:
31.1.2037
Title in English:
1H-INDAZOLE-3-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS FACTOR D INHIBITORS FOR TREATING DISEASES CHARACTERIZED BY ABERRANT COMPLEMENT SYSTEM ACTIVITY, SUCH AS E.G. IMMUNOLOGICAL DISORDERSLanguage of the patent:
English
Timeline
Today
1.2.2017EP application
10.4.2024EP Publication
Owner
Name:
BioCryst Pharmaceuticals, Inc.Address:
4505 Emperor Blvd., Durham, NC 27703, US
Inventor
Name:
KOTIAN, Pravin, LAddress:
Hoover, AL 35226, US
Name:
BABU, Yarlagadda, S.Address:
Birmingham, AL 35244, US
Name:
ZHANG, WeiheAddress:
Vestavia, AL 35226, US
Name:
VOGETI, LakshminarayanaAddress:
Lawrence, KS 66049, US
Name:
WU, MinwanAddress:
Vestavia Hills, AL 35226, US
Name:
CHINTAREDDY, Venkat, R.Address:
Vestavia Hills, AL 35216, US
Name:
RAMAN, KrishnanAddress:
Birmingham, AL 35244, US
Priority
Number:
201662289653 PDate:
1.2.2016Country:
US
Classification
Categories:
C07D 401/12, C07D 231/56, C07D 209/40, C07D 209/48, C07D 487/04, C07D 471/04, C07D 403/12, C07D 403/04, C07D 403/06, C07D 401/14, C07D 401/04, C07D 401/06, C07D 405/12, C07D 209/12, C07D 209/42, A61K 31/416, A61P 37/00, A61P 37/06, A61P 25/00, A61P 21/04, A61K 31/4439, A61K 31/404, A61P 13/00, A61K 31/4035, A61P 13/12, A61P 25/28, A61P 9/00